These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22891713)
1. Sensitive detection of the c-KIT c.1430G>T mutation by mutant-specific polymerase chain reaction in feline mast cell tumours. Takanosu M; Sato M; Kagawa Y Vet Comp Oncol; 2014 Jun; 12(2):138-42. PubMed ID: 22891713 [TBL] [Abstract][Full Text] [Related]
2. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours. Sabattini S; Barzon G; Giantin M; Lopparelli RM; Dacasto M; Prata D; Bettini G Vet Comp Oncol; 2017 Sep; 15(3):1051-1061. PubMed ID: 27278268 [TBL] [Abstract][Full Text] [Related]
3. Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats. Dank G; Chien MB; London CA Am J Vet Res; 2002 Aug; 63(8):1129-33. PubMed ID: 12171166 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours. Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627 [TBL] [Abstract][Full Text] [Related]
5. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours. Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors. Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219 [TBL] [Abstract][Full Text] [Related]
7. Expression of Stem Cell Factor in Feline Mast Cell Tumour. Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375 [TBL] [Abstract][Full Text] [Related]
8. DNA purification increases PCR-amplifiable DNA extracted from formalin-fixed, paraffin-embedded canine mast cell tumors for routine Tamlin VS; Dobson EC; Woolford L; Peaston AE J Vet Diagn Invest; 2019 Sep; 31(5):756-760. PubMed ID: 31378162 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of internal tandem duplications in the c-kit of dogs with multiple mast cell tumours. Amagai Y; Tanaka A; Matsuda A; Jung K; Oida K; Nishikawa S; Jang H; Matsuda H J Small Anim Pract; 2013 Jul; 54(7):377-80. PubMed ID: 23614673 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours. Isotani M; Yamada O; Lachowicz JL; Tamura K; Yagihara H; Fujino Y; Ono K; Washizu T; Bonkobara M Br J Haematol; 2010 Jan; 148(1):144-53. PubMed ID: 19804453 [TBL] [Abstract][Full Text] [Related]
12. Identification of feline polycystic kidney disease mutation using fret probes and melting curve analysis. Criado-Fornelio A; Buling A; Barba-Carretero JC Res Vet Sci; 2009 Feb; 86(1):88-90. PubMed ID: 18556032 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of feline mast cell tumors. Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208 [TBL] [Abstract][Full Text] [Related]
14. Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Zemke D; Yamini B; Yuzbasiyan-Gurkan V Vet Pathol; 2002 Sep; 39(5):529-35. PubMed ID: 12243462 [TBL] [Abstract][Full Text] [Related]
15. The use of COLD-PCR, DHPLC and GeneScanning for the highly sensitive detection of c-KIT somatic mutations in canine mast cell tumours. Gentilini F; Mantovani V; Turba ME Vet Comp Oncol; 2015 Sep; 13(3):218-28. PubMed ID: 23654224 [TBL] [Abstract][Full Text] [Related]
16. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate. Isotani M; Tamura K; Yagihara H; Hikosaka M; Ono K; Washizu T; Bonkobara M Vet Immunol Immunopathol; 2006 Nov; 114(1-2):168-72. PubMed ID: 16908071 [TBL] [Abstract][Full Text] [Related]
17. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study. Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436 [TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit proto-oncogene in canine mastocytoma: a kinetic study using real-time polymerase chain reaction. Turin L; Acocella F; Stefanello D; Oseliero A; Fondrini D; Brizzola S; Riva F J Vet Diagn Invest; 2006 Jul; 18(4):343-9. PubMed ID: 16921872 [TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive significance of KIT protein expression and c-kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology Working Group. Thamm DH; Avery AC; Berlato D; Bulman-Fleming J; Clifford CA; Hershey AE; Intile JL; Jones PD; Kamstock DA; Liptak JM; Pavuk A; Peauroi J; Powell R; Rissetto K; Valli VEO; Webster JD Vet Comp Oncol; 2019 Dec; 17(4):451-455. PubMed ID: 31264352 [TBL] [Abstract][Full Text] [Related]